Breaking News, Financial News

Financial Report: BMS

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Bristol-Myers Squibb  2Q Revenues: $4.9 billion (+1%) 2Q Earnings: $706 million (+6%) YTD Revenues: $9.4 billion (-1%) YTD Earnings: $1.4 billion (flat) Comments: Worldwide pharmaceutical sales were flat at $3.9 billion. U.S. pharmaceutical sales increased 2% to $2.2 billion due to growth of key products and sales of newer products Baraclude, (increased to $59 million, up from $14 million 2Q2006) Orencia (increased to $55 million, up from $18 million) and Sprycel ($35 million...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters